TY - JOUR
T1 - Diagnostic testing and treatment choices in primary vitreoretinal lymphoma
AU - Rajagopal, Rithwick
AU - Harbour, J. William
PY - 2011/3
Y1 - 2011/3
N2 - BACKGROUND: Primary vitreoretinal lymphoma is a rare intraocular malignancy often seen in the context of central nervous system lymphoma. This review updates the current approaches to the management of primary vitreoretinal lymphoma. METHODS: A review of current literature on the management of primary vitreoretinal lymphoma with an emphasis on contemporary diagnostic and treatment methods. RESULTS: Techniques for diagnosing primary vitreoretinal lymphoma from ocular biopsy specimens include cytologic analysis, immunocytochemistry, flow cytometry, polymerase chain reaction to detect V-J immunoglobulin gene rearrangements, and analysis of IL-6 and IL-10 in aqueous or vitreous fluid. Treatment options include external beam radiotherapy, systemic chemotherapy, and intravitreal chemotherapy. CONCLUSION: Cytologic examination of intraocular biopsy specimens remains the gold standard for the diagnosis of PVRL, but ancillary tests can be very helpful in selected patients. Successful primary treatment of the eyes can be accomplished with external beam radiotherapy or intravitreal chemotherapy. Management decisions should be individualized on patient factors, local expertise, and patient preferences. Improvements in molecular diagnostics and local drug delivery are needed to improve the management of PVRL.
AB - BACKGROUND: Primary vitreoretinal lymphoma is a rare intraocular malignancy often seen in the context of central nervous system lymphoma. This review updates the current approaches to the management of primary vitreoretinal lymphoma. METHODS: A review of current literature on the management of primary vitreoretinal lymphoma with an emphasis on contemporary diagnostic and treatment methods. RESULTS: Techniques for diagnosing primary vitreoretinal lymphoma from ocular biopsy specimens include cytologic analysis, immunocytochemistry, flow cytometry, polymerase chain reaction to detect V-J immunoglobulin gene rearrangements, and analysis of IL-6 and IL-10 in aqueous or vitreous fluid. Treatment options include external beam radiotherapy, systemic chemotherapy, and intravitreal chemotherapy. CONCLUSION: Cytologic examination of intraocular biopsy specimens remains the gold standard for the diagnosis of PVRL, but ancillary tests can be very helpful in selected patients. Successful primary treatment of the eyes can be accomplished with external beam radiotherapy or intravitreal chemotherapy. Management decisions should be individualized on patient factors, local expertise, and patient preferences. Improvements in molecular diagnostics and local drug delivery are needed to improve the management of PVRL.
KW - CNS lymphoma
KW - external beam radiotherapy
KW - intraocular lymphoma
KW - methotrexate
KW - rituximab
KW - vitreoretinal lymphoma
UR - http://www.scopus.com/inward/record.url?scp=79952293028&partnerID=8YFLogxK
U2 - 10.1097/IAE.0b013e31820a6743
DO - 10.1097/IAE.0b013e31820a6743
M3 - Review article
C2 - 21336066
AN - SCOPUS:79952293028
SN - 0275-004X
VL - 31
SP - 435
EP - 440
JO - Retina
JF - Retina
IS - 3
ER -